鎌状赤血球貧血検査とスクリーニングの市場規模、シェア、動向分析レポート：技術別、年齢層別、セクタータイプ別、地域別、セグメント予測、2025年～2030年

鎌状赤血球貧血検査とスクリーニング市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の鎌状赤血球貧血検査とスクリーニングの市場規模は、2025～2030年にかけてCAGR 12.1%で拡大し、2030年には8億2,950万米ドルに達する見込みです。

ヘモグロビンS（HbS）は鎌状赤血球症の原因因子であり、現在世界中で、特に新興経済諸国において最も普及している疾患または遺伝子異常です。

鎌状赤血球ヘモグロビンの変異体には、HbS、HbA、HbCがあります。上記の3つのヘモグロビン変異体すべてを明確に区別するために、さまざまな検査が開発されています。スマートフォンの顕微鏡を通じて患者の血液塗抹サンプルから鎌状赤血球貧血の自動スクリーニングを実行するように設計されたディープラーニングフレームワークの開発は、近い将来、市場に新たな道を開くと考えられます。

市場は適度に統合されており、主要な市場参入企業は提携や買収を通じて市場競争を維持し、新生児検査市場全体で事業を拡大しようと努めています。一方、新興企業は市場での競合を獲得するためにポイントオブケア検査の可能性を模索しています。

政府主導の新生児スクリーニング・プログラムや評価研究において、Hb電気泳動やHPLCの利用が急増しており、その結果、市場への浸透が進んでいます。その結果、既存製品ラインの改良に熱心な企業の注目を集め、同製品の消費がさらに拡大しています。

鎌状赤血球貧血検査とスクリーニング市場レポートハイライト

• 年齢層別では、この疾患の負担を効果的に管理するために、世界中でいくつかの新生児スクリーニングプログラムが採用されています。これらのプログラムでは、等電点集束/酢酸セルロース電気泳動、高速液体クロマトグラフィー（HPLC）、溶解度検査などのさまざまな検査が利用されています。
• 技術別では、POCラテラルフローアッセイがスクリーニングプログラムで最も好まれる検査手法であり、従来の検査手段を形成しています。
• セクタータイプ別では、政府検査室が長年にわたり鎌状赤血球検査を最も多く採用してきました。
• 政府検査機関は、集団ベースの鎌状赤血球検査を奨励することにより、これらの検査の採用促進に積極的に参加しています。
• ヘモグロビン異常症や嚢胞性線維症などの疾患の医療格差の治療や診断に対処するための連邦政府や財団の資金提供に対する需要の高まりは、規制機関の注目を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 鎌状赤血球貧血の検査とスクリーニング市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析

第4章 鎌状赤血球貧血検査とスクリーニング市場：技術別、ビジネス分析

• 技術別市場シェア、2024年と2030年
• 技術別セグメントダッシュボード
• 市場規模と予測と動向分析、技術別、2018～2030年
• ヘモグロビン電気泳動
• 高速液体クロマトグラフィー（HPLC）
• ポイントオブケア検査
• その他

第5章 鎌状赤血球貧血検査とスクリーニング市場：年齢層別、ビジネス分析

• 年齢層別市場シェア、2024年と2030年
• 年齢層別セグメントダッシュボード
• 市場規模と予測と動向分析、セクタータイプ別、2018～2030年
• 新生児スクリーニング（12か月以下）
• 成人スクリーニング（25～60歳）
• その他（1～25歳と60歳以上）

第6章 鎌状赤血球貧血検査とスクリーニング市場：セクタータイプ別、ビジネス分析

• セクタータイプ別市場シェア、2024年と2030年
• セクタータイプ別セグメントダッシュボード
• 市場規模と予測と動向分析、セクタータイプ別、2018～2030年
• 政府ラボ
• 民間ラボ
• 企業ラボ
• PPP（官民パートナーシップ）

第7章 鎌状赤血球貧血検査とスクリーニング市場：技術別、地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 国別、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 鎌状赤血球貧血検査とスクリーニング市場：年齢層別、地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 国別、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 鎌状赤血球貧血検査とスクリーニング市場：セクタータイプ別、地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 国別、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 4. Global sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 5. Global sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 6. Global sickle cell anemia testing & screening market, by region, 2018 - 2030 (USD Million)
• Table 7. North America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
• Table 8. North America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 9. North America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 10. North America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 11. U.S. sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 12. U.S. sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 13. U.S. sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 14. Canada sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 15. Canada sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 16. Canada sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 17. Mexico sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 18. Mexico sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 19. Mexico sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 20. Europe sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
• Table 21. Europe sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 22. Europe sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 23. Europe sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 24. UK sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 25. UK sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 26. UK sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 27. Germany sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 28. Germany sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 29. Germany sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 30. France sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 31. France sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 32. France sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 33. Italy sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 34. Italy sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 35. Italy sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 36. Spain sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 37. Spain sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 38. Spain sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 39. Norway sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 40. Norway sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 41. Norway sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 42. Denmark sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 43. Denmark sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 44. Denmark sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 45. Sweden sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 46. Sweden sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 47. Sweden sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 52. Japan sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 53. Japan sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 54. Japan sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 55. China sickle cell anemia testing & screening market, by technology, 2018-2030 (USD Million)
• Table 56. China sickle cell anemia testing & screening market, by age group, 2018-2030 (USD Million)
• Table 57. China sickle cell anemia testing & screening market, by sector type, 2018-2030 (USD Million)
• Table 58. India sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 59. India sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 60. India sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 61. Australia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 62. Australia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 63. Australia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 64. South Korea sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 65. South Korea sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 66. South Korea sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 67. Thailand sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 68. Thailand sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 69. Thailand sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 70. Latin America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
• Table 71. Latin America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 72. Latin America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million
• Table 73. Latin America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million
• Table 74. Brazil sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 75. Brazil sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 76. Brazil sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 77. Argentina sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 78. Argentina sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 79. Argentina sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 84. South Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 85. South Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 86. South Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 90. UAE sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 91. UAE sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 92. UAE sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
• Table 93. Kuwait sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
• Table 94. Kuwait sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
• Table 95. Kuwait sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Sickle cell anemia testing & screening market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Technology outlook (USD Million)
• Fig. 10 Transportation mode outlook (USD Million)
• Fig. 11 Competitive landscape
• Fig. 12 Sickle cell anemia testing & screening market dynamics
• Fig. 13 Sickle cell anemia testing & screening market: Porter's five forces analysis
• Fig. 14 Sickle cell anemia testing & screening market: PESTLE analysis
• Fig. 15 Sickle cell anemia testing & screening market: Technology segment dashboard
• Fig. 16 Sickle cell anemia testing & screening market: Technology market share analysis, 2024 & 2030
• Fig. 17 Hemoglobin electrophoresis market, 2018 - 2030 (USD Million)
• Fig. 18 High-performance liquid chromatography (HPLC) market, 2018 - 2030 (USD Million)
• Fig. 19 Point-of-care tests market, 2018 - 2030 (USD Million)
• Fig. 20 Other tests market, 2018 - 2030 (USD Million)
• Fig. 21 Sickle cell anemia testing & screening market: Age Group segment dashboard
• Fig. 22 Sickle cell anemia testing & screening market: Age Group market share analysis, 2024 & 2030
• Fig. 23 Newborn screening (12 months and below) market, 2018 - 2030 (USD Million)
• Fig. 24 Adult screening (25 to 60 years) market, 2018 - 2030 (USD Million)
• Fig. 25 Other age groups (1 to 25 & above 60 years) market, 2018 - 2030 (USD Million)
• Fig. 26 Sickle cell anemia testing & screening market: Sector type segment dashboard
• Fig. 27 Sickle cell anemia testing & screening market: Sector type market share analysis, 2024 & 2030
• Fig. 28 Government labs market, 2018 - 2030 (USD Million)
• Fig. 29 Private labs market, 2018 - 2030 (USD Million)
• Fig. 30 Corporate labs market, 2018 - 2030 (USD Million)
• Fig. 31 PPP (public private partnerships) market, 2018 - 2030 (USD Million)
• Fig. 32 Sickle cell anemia testing & screening market revenue, by region
• Fig. 33 Regional marketplace: Key takeaways
• Fig. 34 North America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. country dynamics
• Fig. 36 U.S. sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 37 Canada country dynamics
• Fig. 38 Canada sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 39 Mexico country dynamics
• Fig. 40 Mexico sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 41 Europe sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 42 UK country dynamics
• Fig. 43 UK sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 44 Germany country dynamics
• Fig. 45 Germany sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 46 France country dynamics
• Fig. 47 France sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 48 Italy country dynamics
• Fig. 49 Italy sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 50 Spain country dynamics
• Fig. 51 Spain sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 52 Norway country dynamics
• Fig. 53 Norway sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 54 Sweden country dynamics
• Fig. 55 Sweden sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 56 Denmark country dynamics
• Fig. 57 Denmark sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 59 Japan country dynamics
• Fig. 60 Japan sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 61 China country dynamics
• Fig. 62 China sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 63 India country dynamics
• Fig. 64 India sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 65 Australia country dynamics
• Fig. 66 Australia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 67 South Korea country dynamics
• Fig. 68 South Korea sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 69 Thailand country dynamics
• Fig. 70 Thailand sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 71 Latin America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 72 Brazil country dynamics
• Fig. 73 Brazil sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 74 Argentina country dynamics
• Fig. 75 Argentina sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 76 MEA sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 77 South Africa country dynamics
• Fig. 78 South Africa sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 79 Saudi Arabia country dynamics
• Fig. 80 Saudi Arabia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 81 UAE country dynamics
• Fig. 82 UAE sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 83 Kuwait country dynamics
• Fig. 84 Kuwait sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
• Fig. 85 Company categorization
• Fig. 86 Company market position analysis
• Fig. 87 Strategic framework

Sickle Cell Anemia Testing And Screening Market Growth & Trends:

The global sickle cell anemia testing and screening market size is expected to reach USD 829.5 million by 2030, expanding at a CAGR of 12.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.

A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.

Sickle Cell Anemia Testing And Screening Market Report Highlights:

• By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
• Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
• On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
• Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
• Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Age Group
  • 1.2.3. Sector Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Sickle Cell Anemia Testing & Screening Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Sickle Cell Anemia Testing & Screening Market: Technology Business Analysis

• 4.1. Technology Market Share, 2024 & 2030
• 4.2. Technology Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 4.4. Hemoglobin Electrophoresis
  • 4.4.1. Hemoglobin Electrophoresis Market, 2018 - 2030 (USD Million)
  • 4.4.2. Isoelectric Focusing
    • 4.4.2.1. Isoelectric Focusing Market, 2018 - 2030 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. High-Performance Liquid Chromatography (HPLC)
  • 4.5.1. High-Performance Liquid Chromatography (HPLC) Market, 2018 - 2030 (USD Million)
• 4.6. Point-of-Care Tests
  • 4.6.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)
  • 4.6.2. Lateral Flow Immunoassay
    • 4.6.2.1. Lateral Flow Immunoassay Market, 2018 - 2030 (USD Million)
  • 4.6.3. Paper-Based Rapid Diagnostics
    • 4.6.3.1. Paper-Based Rapid Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.6.4. Others
    • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
• 4.7. Other Tests
  • 4.7.1. Other Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Sickle Cell Anemia Testing & Screening Market: Age Group Business Analysis

• 5.1. Age Group Market Share, 2024 & 2030
• 5.2. Age Group Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
• 5.4. Newborn Screening (12 months and below)
  • 5.4.1. Newborn Screening (12 months and below) Market, 2018 - 2030 (USD Million)
• 5.5. Adult Screening (25 to 60 years)
  • 5.5.1. Adult Screening (25 to 60 years) Market, 2018 - 2030 (USD Million)
• 5.6. Other Age Groups (1 to 25 & above 60 years)
  • 5.6.1. Other Age Groups (1 to 25 & above 60 years) Market, 2018 - 2030 (USD Million)

Chapter 6. Sickle Cell Anemia Testing & Screening Market: Sector Type Business Analysis

• 6.1. Sector Type Market Share, 2024 & 2030
• 6.2. Sector Type Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Sector Type, 2018 to 2030 (USD Million)
• 6.4. Government Labs
  • 6.4.1. Government Labs Market, 2018 - 2030 (USD Million)
• 6.5. Private Labs
  • 6.5.1. Private Labs Market, 2018 - 2030 (USD Million)
• 6.6. Corporate Labs
  • 6.6.1. Corporate Labs Market, 2018 - 2030 (USD Million)
• 6.7. PPP (Public-Private-Partnerships)
  • 6.7.1. PPP (Public-Private-Partnerships) Market, 2018 - 2030 (USD Million)

Chapter 7. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Technology

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Age Group

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework
    • 8.4.2.3. Competitive Insights
    • 8.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework
    • 8.4.3.3. Competitive Insights
    • 8.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Regulatory Framework
    • 8.4.4.3. Competitive Insights
    • 8.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework
    • 8.5.2.3. Competitive Insights
    • 8.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework
    • 8.5.3.3. Competitive Insights
    • 8.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework
    • 8.5.4.3. Competitive Insights
    • 8.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework
    • 8.5.5.3. Competitive Insights
    • 8.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework
    • 8.5.6.3. Competitive Insights
    • 8.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework
    • 8.5.7.3. Competitive Insights
    • 8.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework
    • 8.5.8.3. Competitive Insights
    • 8.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Sweden
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Regulatory Framework
    • 8.5.9.3. Competitive Insights
    • 8.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Insights
    • 8.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Insights
    • 8.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework
    • 8.6.4.3. Competitive Insights
    • 8.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework
    • 8.6.5.3. Competitive Insights
    • 8.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework
    • 8.6.6.3. Competitive Insights
    • 8.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Framework
    • 8.6.7.3. Competitive Insights
    • 8.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Framework
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Sector Type

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Framework
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Framework
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Framework
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Framework
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Framework
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Framework
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Regulatory Framework
    • 9.5.5.3. Competitive Insights
    • 9.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Regulatory Framework
    • 9.5.6.3. Competitive Insights
    • 9.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Regulatory Framework
    • 9.5.7.3. Competitive Insights
    • 9.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Denmark
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Regulatory Framework
    • 9.5.8.3. Competitive Insights
    • 9.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Sweden
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Regulatory Framework
    • 9.5.9.3. Competitive Insights
    • 9.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Framework
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Framework
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Framework
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. South Korea
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Framework
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. Australia
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Regulatory Framework
    • 9.6.6.3. Competitive Insights
    • 9.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Regulatory Framework
    • 9.6.7.3. Competitive Insights
    • 9.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)